Ritchie A W, James K, Micklem H S, Chisholm G D
Br J Urol. 1984 Apr;56(2):140-8. doi: 10.1111/j.1464-410x.1984.tb05349.x.
Using monoclonal antibodies in conjunction with flow cytometry, circulating lymphocyte subsets with distinct functions in the regulation of the immune response were enumerated in 32 patients with proven renal carcinoma. Analyses were performed at presentation and sequentially during the clinical course of the patients. Untreated patients with advanced disease had a deficit of T cells with the "helper/inducer" phenotype (Leu-3a+) and this resulted in abnormal T "helper/suppressor" (Leu-3a+/Leu-2a+) ratios. Following nephrectomy, performed in 26 patients, there was a significant increase in the number of T cells with the "helper/inducer" phenotype and a significant increase in T "H/S" ratios. Subsequent follow-up at a minimum of 2 months after nephrectomy showed that the increase in T cells with the "helper/inducer" phenotype was maintained (with the exception of 6 patients with disease progression) and was then accompanied by a significant increase of the T cell subset with the "suppressor/cytotoxic" phenotype (Leu-2a+). Pre-operative renal arterial embolisation resulted in an early transient lymphopenia. The response to embolisation combined with nephrectomy was little different when compared with nephrectomy alone. These observations represent a novel view of the immunosuppressive effects of renal carcinoma and their relation to anaemia and disease progression are discussed.
利用单克隆抗体结合流式细胞术,对32例经证实的肾癌患者中在免疫反应调节方面具有不同功能的循环淋巴细胞亚群进行了计数。在患者就诊时以及临床病程中依次进行分析。未经治疗的晚期疾病患者具有 “辅助/诱导” 表型(Leu-3a+)的T细胞数量不足,这导致T “辅助/抑制”(Leu-3a+/Leu-2a+)比值异常。在26例患者接受肾切除术后,具有 “辅助/诱导” 表型的T细胞数量显著增加,T “辅助/抑制” 比值也显著增加。肾切除术后至少2个月的后续随访显示,具有 “辅助/诱导” 表型的T细胞数量持续增加(6例疾病进展患者除外),随后具有 “抑制/细胞毒性” 表型(Leu-2a+)的T细胞亚群显著增加。术前肾动脉栓塞导致早期短暂性淋巴细胞减少。与单纯肾切除术相比,栓塞联合肾切除术的反应差异不大。这些观察结果代表了对肾癌免疫抑制作用的新观点,并讨论了它们与贫血和疾病进展的关系。